Part 3/Chapter 11/9-min read

Systemic Complications of Vascular Disease and Intervention

Systemic complications of vascular disease and intervention organized by threatened organ system: heart, brain, kidney, lung, spinal cord, venous system, and cognition. The chapter ties each complication to its preventable patient, operative, or device driver.

Edited by Tal M. Hörer MD, PhD · David T. McGreevy MD, PhD·Version 1 · Last published ·6 sections · 43 references

Revision history

Listen to this chapter5 min · AI audio edition · two hostsAI narration

Choose a chapter overview or a specialist discussion. Each recording follows this published edition.

General medical education, not patient-specific advice.

Choose an audio edition

Preoperative risk integration

Systemic complications after vascular intervention encompass cardiac, neurologic, renal, pulmonary, and cognitive organ-system failures. Contemporary perioperative cardiovascular assessment relies on procedural urgency, functional capacity, and condition-specific cardiac risk; additional noninvasive testing is reserved for scenarios where the result alters anesthesia, monitoring, or the operative approach . Urgent or emergent limb- and life-saving operations proceed without elective workup delays.

TreatmentSystemic Perioperative Action Checklist
  • Cardiac
    Before intervention
    Establish urgency, symptoms, functional capacity and cardiovascular risk; investigate new decompensation, not every stable patient.
    Perioperative response
    Define blood-pressure monitoring and whether postoperative troponin surveillance is appropriate.
  • Pulmonary
    Before intervention
    Review respiratory symptoms, oxygenation and existing lung disease; investigate deterioration selectively.
    Perioperative response
    Plan analgesia, respiratory support and mobilization; routine chest radiography/spirometry is not an elective-AAA requirement.
  • Renal and blood conservation
    Before intervention
    Record baseline renal function/electrolytes, hemoglobin, anticipated contrast exposure and bleeding burden.
    Perioperative response
    Track urine output, creatinine and bleeding; correct hemodynamic causes and review nephrotoxic exposures. A transfusion association is not itself a transfusion threshold.
  • Medicines, function and discharge
    Before intervention
    Reconcile anticoagulant/antiplatelet indications and functional support; assign responsibility for hold/restart decisions.
    Perioperative response
    Reassess bleeding versus after complications and arrange a documented handoff. Use the medication table in Chapter 10 rather than duplicating a second regimen.

The anemia associations below remain relevant but do not replace this organ-system assessment.

Systemic protection includes rigorous blood conservation and management. In elective open abdominal aortic repair, perioperative red-blood-cell transfusion exposure is independently associated with increased postoperative morbidity and mortality . Postoperative anemia within defined hemoglobin thresholds is independently associated with acute kidney injury after open aortic and vena-caval surgery .

Cardiovascular complications

Cardiac complications after vascular surgery frequently manifest without ischemic symptoms. Approximately 66% of perioperative myocardial infarctions in noncardiac surgery cohorts are asymptomatic, yet carry substantially higher 30-day mortality . Myocardial injury after noncardiac surgery () is defined by postoperative high-sensitivity troponin elevation above the assay 99th percentile attributed to ischemia, independent of chest pain or electrocardiographic changes . In vascular surgery patients, postoperative myocardial injury is independently associated with major non-cardiac complications at 30 days, including renal, neurologic, infectious, and bleeding events; preoperative cardiac biomarker levels do not predict this non-cardiac complication burden .

New-onset perioperative atrial fibrillation is associated with increased late mortality compared with sinus rhythm after abdominal aortic aneurysm repair . After descending aortic repair, new atrial fibrillation correlates with cross-clamp time and pre-existing pulmonary disease . Observational anticoagulation evidence in new perioperative atrial fibrillation does not justify treating every episode identically . For a new arrhythmia, obtain an electrocardiogram, assess hemodynamic stability and address precipitating bleeding, hypoxia, electrolyte disturbance or infection. Select rate/rhythm treatment and the timing of anticoagulation according to thromboembolic risk and operative hemostasis; arrange reassessment for recurrence .

For a postoperative troponin rise, review the preoperative value and serial change, obtain an electrocardiogram, and assess symptoms and hemodynamics. Assess for acute coronary occlusion, supply–demand imbalance, pulmonary , sepsis and arrhythmia, and determine whether the injury is attributable to ischemia. Correct supply–demand contributors and involve cardiology urgently for suspected acute coronary occlusion or instability; a troponin result alone is not an instruction to begin full-dose antithrombotic treatment across a fresh vascular reconstruction .

Pulmonary and renal complications

Chronic obstructive pulmonary disease is more prevalent in patients with abdominal aortic aneurysms and is independently associated with increased perioperative mortality after both open and endovascular repair . Postoperative severe pulmonary complication rates approach 10% in aortic surgery cohorts . Risk stratification uses the ARISCAT 7-predictor score and vascular-specific registry models to guide intensified respiratory planning rather than routine postoperative observation .

Postoperative acute kidney injury is defined by KDIGO criteria . Acute kidney injury affects roughly 60% of patients after elective open abdominal aortic aneurysm surgery, with 25% developing KDIGO stage 2 or 3 injury within 24 hours . Routine parameters including cystatin C or creatinine, early urine osmolality, and early urine output outperform novel cell-cycle-arrest biomarkers for early prediction. Preoperative renal dysfunction and ruptured presentation are key risk factors for severe postoperative acute kidney injury and mortality . Complex endovascular aneurysm repair produces early acute kidney injury and long-term estimated glomerular filtration rate decline in a notable subset, while pararenal aneurysm data demonstrate discrete injury patterns from suprarenal clamping versus renovisceral catheter-time exposure . Externally validated prediction models for noncardiac surgical acute kidney injury achieve only fair discrimination after recalibration .

Neurologic and spinal cord complications

Perioperative stroke is stratified mechanistically into embolic, hemodynamic, and lacunar pathways. Modifiable intraoperative contributors include hypotension, new-onset atrial fibrillation, and antithrombotic therapy interruption; prior stroke remains the strongest non-modifiable risk factor . Strokes recognized intraoperatively or in the immediate postoperative window carry the highest short-term mortality . Ischemic stroke is defined by central-nervous-system infarction on imaging, pathology, or persistent clinical findings . Patent foramen ovale is associated with elevated perioperative stroke risk, but absolute rates remain low and routine preoperative screening is not indicated .

Aortic surgery concentrates significant neurologic hazard. In open thoracoabdominal aortic aneurysm repair, contemporary large-volume centers achieve operative mortality in the high single digits, but permanent paraplegia or paraparesis still occurs in roughly 5% of patients, and dialysis-requiring renal failure at a low single-digit rate . Pooled modern descending thoracic and thoracoabdominal aneurysm data report permanent spinal cord injury in approximately 3% of patients overall, with open repair carrying a modestly higher permanent injury risk than endovascular repair .

Delirium, venous thromboembolism, and antithrombotic management

Venous thromboembolism () affects roughly 3% of major vascular surgery patients. Risk is highest in open aortic reconstruction and thoracic endovascular operations, and lowest in routine peripheral bypass and infrarenal . Over one-third of VTE events occur within 90 days of discharge, and delaying postoperative prophylaxis beyond four days doubles VTE odds. Dual antiplatelet therapy duration after coronary stenting involves balancing ischemic against bleeding risk, necessitating reconciliation with active local guidance before therapy interruption . When elective noncardiac surgery requires interruption of antiplatelet therapy after coronary drug-eluting stenting, the 2024 guideline distinguishes acute coronary syndrome (ideally delay at least 12 months) from chronic coronary disease (a delay of at least 6 months is reasonable). Time-sensitive surgery may be considered after at least 3 months when delaying surgery is more hazardous. Interruption within 30 days of either bare-metal or drug-eluting stenting is particularly hazardous. Timing and continuation of aspirin or dual antiplatelet therapy require a coordinated surgical–cardiology decision, not the older undifferentiated 6-month rule .

Delirium, VTE prophylaxis, and antithrombotic decisions

  • Delirium prevention

    Patient profile
    Older adults, open aortic repair, emergent operations, or amputation
    Management strategy
    Implement a multicomponent prevention bundle avoiding routine benzodiazepine sedation and anticholinergics
    Citation

  • VTE prophylaxis

    Patient profile
    Vascular admission
    Management strategy
    Assign mechanical or pharmacologic prophylaxis based on documented bleeding versus thrombosis risk; reassess after hemorrhage or reoperation
    Citation

  • Perioperative antithrombotics

    Patient profile
    Elective or urgent surgery on chronic anticoagulation
    Management strategy
    Document a single perioperative plan stating indication, planned hold, bridging rationale, and resumption trigger
    Citation

  • Dual pathway therapy

    Patient profile
    Post-lower extremity revascularization for symptomatic
    Management strategy
    Initiate rivaroxaban 2.5 mg twice daily plus aspirin if bleeding risk permits, to reduce major adverse limb and cardiovascular events
    Citation

  • Secondary prevention

    Patient profile
    Stable atherosclerotic cardiovascular disease
    Management strategy
    Use low-dose rivaroxaban plus aspirin to reduce major adverse events compared to aspirin alone
    Citation

Postoperative delirium incidence in vascular cohorts ranges from 5% to 40% . Risk modifiers include open aneurysm repair, emergent operations, advanced age, dementia, renal impairment, and major amputation. Delirium affects approximately 33% of open abdominal aortic aneurysm patients and correlates with prolonged intensive-care stays and elevated 90-day mortality . A multimodal prehabilitation pathway combining risk assessment, exercise, and nutritional optimization is associated with shorter hospital stays and a trend toward reduced delirium in elective aortic surgery . Regional anesthesia does not lower the 7-day delirium incidence compared with general anesthesia .

Perioperative complication risk frameworks

  • Cardiac risk

    Evaluation strategy
    Base noninvasive testing on urgency, functional capacity, and condition-specific risk
    Threshold or interpretation
    Proceed without elective testing if the result will not alter anesthesia, monitoring, or operative approach
    Citation

  • Myocardial injury

    Evaluation strategy
    Risk-selected postoperative troponin surveillance and clinical assessment
    Threshold or interpretation
    An elevated result requires classification; MINS requires an ischemic attribution, not merely an above-threshold troponin.
    Citation

  • Postoperative atrial fibrillation

    Evaluation strategy
    Confirm rhythm, assess triggers, stroke risk and current hemostasis
    Threshold or interpretation
    Decide whether and when anticoagulation is justified, and arrange recurrence/risk reassessment; do not initiate it automatically for every episode.
    Citation

  • Acute kidney injury

    Evaluation strategy
    KDIGO-aligned diagnostic framework with early urine output and osmolality
    Threshold or interpretation
    Identify injury early; occurs in up to 60% of open cases with 25% developing KDIGO stage 2 or 3 within 24 hours
    Citation

Areas of controversy

The mechanism of perioperative stroke remains probabilistic in routine practice, as definitive classification often escapes full clinical workup . The stroke-reduction benefit versus the bleeding risk of anticoagulation for new-onset perioperative atrial fibrillation is supported primarily by observational data rather than randomized comparisons in the specific postoperative setting . Predictive models for postoperative acute kidney injury demonstrate limited discrimination upon external validation despite contemporary care pathways . Finally, direct evidence mandating specific pharmacologic over mechanical venous thromboembolism prophylaxis in vascular surgery remains limited and heterogeneous across specific procedures .

Further reading

  • Atrial fibrillation in vascular surgery: a systematic review and meta-analysis on prevalence, incidence and outcome implications. (2023). Perioperative atrial fibrillation in vascular surgery.
  • Spinal cord injury after open and endovascular repair of descending thoracic aneurysm and thoracoabdominal aortic aneurysm: an updated systematic review and meta-analysis. (2023). Spinal cord injury after descending and thoracoabdominal aortic repair.

References

  1. 1.
    2024 AHA/ACC multisociety guideline for perioperative cardiovascular management for noncardiac surgery. 2024.
    PubMed-indexed articleClinical practice guideline2024

    2024 AHA/ACC multisociety guideline for perioperative cardiovascular management for noncardiac surgery. 2024. doi:10.1161/cir.0000000000001285.

    PubMedDOI
  2. 2.
    Red blood cell transfusion associated with increased morbidity and mortality in patients undergoing elective open abdominal aortic aneurysm repair DOI: 10.1371/journal.pone.0219263
    PubMed-indexed articleRegistry / cohort2019
    PubMedDOIOpen PDF
  3. 3.
    Postoperative anemia is a risk factor for acute kidney injury after open aorta and vena cava surgeries DOI: 10.1371/journal.pone.0240243
    PubMed-indexed articleRegistry / cohort2020
    PubMedDOIOpen PDF
  4. 4.
    Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery: a cohort study. 2011.
    PubMed-indexed articleRegistry / cohort2011

    Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery: a cohort study. 2011. doi:10.7326/0003-4819-154-8-201104190-00003.

    PubMedDOI
  5. 5.
    Diagnosis and Management of Patients With Myocardial Injury After Noncardiac Surgery: A Scientific Statement From the American Heart Association. Circulation. 2021.
    PubMed-indexed article2021

    Diagnosis and Management of Patients With Myocardial Injury After Noncardiac Surgery: A Scientific Statement From the American Heart Association. Circulation. 2021. doi:10.1161/cir.0000000000001024.

    PubMedDOI
  6. 6.
    Perioperative myocardial injury is associated with increased postoperative non-cardiac complications in patients undergoing vascular surgery: a post hoc analysis of a randomised clinical pilot trial DOI: 10.1186/s13741-023-00350-y
    PubMed-indexed articleRandomized controlled trial2023
    PubMedDOIOpen PDF
  7. 7.
    Transient postoperative atrial fibrillation after abdominal aortic aneurysm repair increases mortality risk DOI: 10.1016/j.jvs.2015.12.046
    PubMed-indexed articleRegistry / cohort2015
    PubMedDOIOpen PDF
  8. 8.
    Atrial Fibrillation after Descending Aorta Repair: Occurrence, Risk Factors, and Impact on Outcomes DOI: 10.1055/s-0043-1770960
    PubMed-indexed articleRegistry / cohort2023
    PubMedDOIOpen PDF
  9. 9.
    Anticoagulation use in perioperative atrial fibrillation after noncardiac surgery: a systematic review and meta-analysis. Swiss medical weekly. 2023.
    PubMed-indexed articleMeta-analysis / systematic review2023

    Anticoagulation use in perioperative atrial fibrillation after noncardiac surgery: a systematic review and meta-analysis. Swiss medical weekly. 2023. doi:10.57187/smw.2023.40056.

    PubMedDOI
  10. 10.
    Atrial fibrillation in vascular surgery: a systematic review and meta-analysis on prevalence, incidence and outcome implications DOI: 10.2459/JCM.0000000000001533
    PubMed-indexed articleMeta-analysis / systematic review2023
    PubMedDOIOpen PDF
  11. 11.
    Chronic obstructive pulmonary disease effect on the prevalence and postoperative outcome of abdominal aortic aneurysms: A meta-analysis DOI: 10.1038/srep25003
    PubMed-indexed articleMeta-analysis / systematic review2016
    PubMedDOIOpen PDF
  12. 12.
    Epidemiology, practice of ventilation and outcome for patients at increased risk of postoperative pulmonary complications: LAS VEGAS - an observational study in 29 countries DOI: 10.1097/EJA.0000000000000646
    PubMed-indexed article2017
    PubMedDOIOpen PDF
  13. 13.
    Prediction of postoperative pulmonary complications in a population-based surgical cohort DOI: 10.1097/ALN.0b013e3181fc6e0a
    PubMed-indexed articleRegistry / cohort2010
    PubMedDOI
  14. 14.
    Risk stratification for the development of respiratory adverse events following vascular surgery using the Society of Vascular Surgery's Vascular Quality Initiative DOI: 10.1016/j.jvs.2016.07.119
    PubMed-indexed articleRegistry / cohort2016
    PubMedDOIOpen PDF
  15. 15.
    Pulmonary Complications After Open Abdominal Aortic Surgery: A Systematic Review and Meta-Analysis DOI: 10.1053/j.jvca.2016.09.034
    PubMed-indexed articleMeta-analysis / systematic review2016
    PubMedDOI
  16. 16.
    Postoperative Acute Kidney Injury DOI: 10.2215/CJN.16541221
    PubMed-indexed articleReview2022
    PubMedDOIOpen PDF
  17. 17.
    Biomarker-guided detection of acute kidney injury in abdominal aortic surgery: the new and the old DOI: 10.3389/fmed.2024.1386018
    PubMed-indexed articleRegistry / cohort2024
    PubMedDOIOpen PDF
  18. 18.
    The incidence, risk factors and in-hospital mortality of acute kidney injury in patients after abdominal aortic aneurysm repair surgery DOI: 10.1186/s12882-017-0594-6
    PubMed-indexed articleRegistry / cohort2017
    PubMedDOIOpen PDF
  19. 19.
    Occurrences and Results of Acute Kidney Injury after Endovascular Aortic Abdominal Repair? DOI: 10.5758/vsi.2017.33.4.135
    PubMed-indexed articleRegistry / cohort2017
    PubMedDOIOpen PDF
  20. 20.
    Endovascular treatment of complex aortic aneurysms: prevalence of acute kidney injury and effect on long-term renal function DOI: 10.1007/s00330-015-3993-8
    PubMed-indexed articleRegistry / cohort2016
    PubMedDOIOpen PDF
  21. 21.
    Comparative study of acute kidney injury in pararenal aortic aneurysm: open surgical versus endovascular repair DOI: 10.3389/fsurg.2024.1457583
    PubMed-indexed articleRegistry / cohort2024
    PubMedDOIOpen PDF
  22. 22.
    Preoperative risk prediction models for acute kidney injury after noncardiac surgery: an independent external validation cohort study. British journal of anaesthesia. 2024.
    PubMed-indexed articleMeta-analysis / systematic review2024

    Preoperative risk prediction models for acute kidney injury after noncardiac surgery: an independent external validation cohort study. British journal of anaesthesia. 2024. doi:10.1016/j.bja.2024.02.018.

    PubMedDOI
  23. 23.
    Prevention of perioperative stroke in patients undergoing non-cardiac surgery. The Lancet. Neurology. 2023.
    PubMed-indexed articleReview2023

    Prevention of perioperative stroke in patients undergoing non-cardiac surgery. The Lancet. Neurology. 2023. doi:10.1016/s1474-4422(23)00209-0.

    PubMedDOI
  24. 24.
    Perioperative Stroke: Mechanisms, Risk Stratification, and Management. Stroke. 2025.
    PubMed-indexed articleReview2025

    Perioperative Stroke: Mechanisms, Risk Stratification, and Management. Stroke. 2025. doi:10.1161/strokeaha.125.051673.

    PubMedDOI
  25. 25.
    Timing of Postoperative Stroke and Risk of Mortality After Noncardiac Surgery: A Cohort Study. Journal of clinical medicine research. 2023.
    PubMed-indexed articleRegistry / cohort2023

    Timing of Postoperative Stroke and Risk of Mortality After Noncardiac Surgery: A Cohort Study. Journal of clinical medicine research. 2023. doi:10.14740/jocmr4877.

    PubMedDOI
  26. 26.
    An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. 2013.
    PubMed-indexed article2013

    An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. 2013. doi:10.1161/str.0b013e318296aeca.

    PubMedDOI
  27. 27.
    Patent foramen ovale and perioperative stroke in noncardiac surgery: a systematic review and meta-analysis. British journal of anaesthesia. 2022.
    PubMed-indexed articleMeta-analysis / systematic review2022

    Patent foramen ovale and perioperative stroke in noncardiac surgery: a systematic review and meta-analysis. British journal of anaesthesia. 2022. doi:10.1016/j.bja.2022.06.036.

    PubMedDOI
  28. 28.
    Results of open thoracoabdominal aortic aneurysm repair DOI: 10.3978/j.issn.2225-319X.2012.08.16
    PubMed-indexed articleRegistry / cohort2012
    PubMedDOIOpen PDF
  29. 29.
    Spinal cord injury after open and endovascular repair of descending thoracic aneurysm and thoracoabdominal aortic aneurysm: an updated systematic review and meta-analysis DOI: 10.21037/acs-2023-scp-14
    PubMed-indexed articleMeta-analysis / systematic review2023
    PubMedDOIOpen PDF
  30. 30.
    Risk Factors for Delirium after Vascular Surgery: A Systematic Review and Meta-Analysis. Annals of vascular surgery. 2021.
    PubMed-indexed articleMeta-analysis / systematic review2021

    Risk Factors for Delirium after Vascular Surgery: A Systematic Review and Meta-Analysis. Annals of vascular surgery. 2021. doi:10.1016/j.avsg.2021.03.034.

    PubMedDOI
  31. 31.
    Risk factors and associated outcomes of postoperative delirium after open abdominal aortic aneurysm repair. Journal of vascular surgery. 2024.
    PubMed-indexed articleRegistry / cohort2024

    Risk factors and associated outcomes of postoperative delirium after open abdominal aortic aneurysm repair. Journal of vascular surgery. 2024. doi:10.1016/j.jvs.2023.11.040.

    PubMedDOI
  32. 32.
    The Potential Value of Prehabilitation for Preventing Delirium in Elective Surgery for Aneurysms of the Abdominal Aorta DOI: 10.2147/CIA.S420861
    PubMed-indexed articleRegistry / cohort2024
    PubMedDOIOpen PDF
  33. 33.
    Effect of Regional vs General Anesthesia on Incidence of Postoperative Delirium in Older Patients Undergoing Hip Fracture Surgery: The RAGA Randomized Trial. JAMA. 2022.
    PubMed-indexed articleRandomized controlled trial2022

    Effect of Regional vs General Anesthesia on Incidence of Postoperative Delirium in Older Patients Undergoing Hip Fracture Surgery: The RAGA Randomized Trial. JAMA. 2022. doi:10.1001/jama.2021.22647.

    PubMedDOI
  34. 34.
    A meta-analysis and systematic review of venous thromboembolism prophylaxis in patients undergoing vascular surgery procedures. Journal of vascular surgery. Venous and lymphatic disorders. 2020.
    PubMed-indexed articleMeta-analysis / systematic review2020

    A meta-analysis and systematic review of venous thromboembolism prophylaxis in patients undergoing vascular surgery procedures. Journal of vascular surgery. Venous and lymphatic disorders. 2020. doi:10.1016/j.jvsv.2020.03.017.

    PubMedDOI
  35. 35.
    Risk factors for venous thromboembolism after vascular surgery and implications for chemoprophylaxis strategies DOI: 10.1016/j.jvsv.2021.10.001
    PubMed-indexed articleRegistry / cohort2021
    PubMedDOIOpen PDF
  36. 36.
    2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. Circulation. 2016.
    PubMed-indexed articleClinical practice guideline2016

    2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. Circulation. 2016. doi:10.1161/cir.0000000000000404.

    PubMedDOI
  37. 37.
    American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on Postoperative Delirium Prevention. Anesthesia and analgesia. 2020.
    PubMed-indexed articleClinical practice guideline2020

    American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on Postoperative Delirium Prevention. Anesthesia and analgesia. 2020. doi:10.1213/ane.0000000000004641.

    PubMedDOI
  38. 38.
    European guidelines on peri-operative venous thromboembolism prophylaxis: first update. Executive summary. European journal of anaesthesiology. 2024.
    PubMed-indexed articleClinical practice guideline2024

    European guidelines on peri-operative venous thromboembolism prophylaxis: first update. Executive summary. European journal of anaesthesiology. 2024. doi:10.1097/eja.0000000000002025.

    PubMedDOI
  39. 39.
    American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients DOI: 10.1182/bloodadvances.2019000975
    PubMed-indexed articleClinical practice guideline2019
    PubMedDOIOpen PDF
  40. 40.
    Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
    PubMed-indexed articleClinical practice guideline2012

    Holbrook A, Schulman S, Witt DM, Vandvik PO, Fish J, Kovacs MJ, et al. Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e152S-e184S. doi:10.1378/chest.11-2295. PMID:22315259.

    PubMedDOI
  41. 41.
    Rivaroxaban in Peripheral Artery Disease after Revascularization. 2020.
    PubMed-indexed articleRandomized controlled trial2020

    Rivaroxaban in Peripheral Artery Disease after Revascularization. 2020. doi:10.1056/nejmoa2000052.

    PubMedDOI
  42. 42.
    Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. 2017.
    PubMed-indexed articleRandomized controlled trial2017

    Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. 2017. doi:10.1056/nejmoa1709118.

    PubMedDOI
  43. 43.
    Editor's Choice - European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Abdominal Aorto-Iliac Artery Aneurysms 2024-02.
    PubMed-indexed article2024

    Editor's Choice - European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Abdominal Aorto-Iliac Artery Aneurysms 2024-02. doi:10.1016/j.ejvs.2023.11.002.

    PubMedDOISource

Educational use only

AI assists this editorial workflow. Published updates are human-reviewed before publication.

Not intended to diagnose, monitor, predict, prognose, treat, or alleviate disease.

Verify clinically relevant information against primary sources and current guidelines.

AI DisclosurePrivacyTermsCautions
Updates and feedback

You are reading the published chapter.

What has changed

Loading the change history…

Report a problem